Involvement of cytochromes P-450 2E1 and 3A4 in the 5-hydroxylation of salicylate in humans

Drug Metabolism and Disposition

Volumn 27, Issue 3, 1999, Pages 322-326

  Dupont, Isabelle ^a   Berthou, François ^a   Bodenez, Pierre ^a   Bardou, Louis ^a   Guirriec, Caroline ^a   Stephan, Nathalie ^a   Dreano, Yvonne ^a   Lucas, Danièle ^a  

^a FACULTÉ DE MÉDECINE ET DES SCIENCES DE LA SANTÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; LYSINE ACETYLSALICYLATE; NIFEDIPINE;

ALCOHOLISM; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DETERMINATION; DRUG HYDROXYLATION; DRUG METABOLISM; ENZYME ACTIVITY; ENZYME ANALYSIS; HUMAN; HUMAN CELL; LIVER MICROSOME METABOLISM; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ALCOHOLISM; CYTOCHROME P-450 CYP2E1; CYTOCHROME P-450 ENZYME SYSTEM; GENTISATES; HUMANS; HYDROXYBENZOIC ACIDS; HYDROXYLATION; KINETICS; MICROSOMES, LIVER; MIXED FUNCTION OXYGENASES; SALICYLATES;

EID: 0032965218     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Bellec G, Dréano Y, Lozach P, Ménez JF and Berthou F (1996) Cytochrome P450 metabolic dealkylation of nine N-nitrosodialkylamines by human liver microsomes. Carcinogenesis 17:2029-2034.
2. Berthou F, Flinois JP, Ratanasavanh D, Beaune P, Riché C and Guillouzo A (1991) Evidence for the involvement of several cytochromes P450 in the first steps of caffeine metabolism by human liver microsomes. Drug Metab Dispos 19:561-567.
3. Coudray C, Talla M, Martin S, Fatôme M and Favier A (1995) High performance liquid chromatography-electrochemical determination of salicylate hydroxylation products as in vivo marker of oxidative stress. Anal Biochem 227:101-111.
4. Day RO, Furst DE, Dromgoole SH and Paulus HF (1988) Changes in salicylate serum concentration and metabolism during chronic dosing in normal volunteers. Biopharm Drug Dispos 9:273-283.
5. Girre C, Lucas D, Hispard E, Ménez C, Dally S and Ménez JF (1994) Assessment of cytochrome P450 2E1 induction in alcoholic patients by chlorzoxazone pharmacokinetics. Biochem Pharmacol 47:1503-1508.
6. Grootveld M and Halliwell B (1988) 2,3-dihydroxybenzoic acid is a product of human aspirin metabolism. Biochem Pharmacol 37:271-280.
7. Guengerich FP and Turvy CG (1991) Comparison of levels of several human microsomal cytochrome P450 enzymes and epoxide hydrolase in normal and disease state using immunochemical analysis of surgical liver samples. J Pharmacol Exp Ther 256:1189-1194.
8. Guengerich FP, Kim DH and Iwasaki M (1991) Role of human cytochrome P450 2E1 in the oxidation of many low molecular weight cancer suspects. Chem Res Toxicol 4:168-179.
9. Halliwell B and Kaur H (1997) Hydroxylation of salicylate and phenylalanine as assay for hydroxyl radicals: A cautionary note visited for the third time. Free Rad Res 27:239-244.
10. Halliwell B, Kaur H and Ingelman-Sundberg M (1991) Hydroxylation of salicylate as an assay for hydroxyl radicals: A cautionary note. Free Rad Biol Med 10:439-441.
11. Hoshino U and Kawasaki H (1995) Urinary 6β-hydroxycortisol excretion in patients with alcoholic liver disease. Alcohol Sub Abuse 16:116-124.
12. Ingelman-Sundberg M, Kaur H, Terelius Y, Persson JO and Halliwell B (1991) Hydroxylation of salicylate by microsomal fractions and cytochromes P450. Biochem J 276:753-757.
13. Iribarne C, Picart D, Dréano Y, Bail JP and Berthou F (1997) Involvement of cylochrome P450 3A4 in the N-dealkylation of buprenorphine in human liver microsomes. Life Sci 60:1953-1964.
14. Jacolot F, Simon I, Dréano Y, Beaune P, Riché C and Berthou F (1991) Identification of the cytochrome P450 IIIA as the enzymes involved in the N-demethylation of tamoxifen in human liver microsomes. Biochem Pharmacol 41:1911-1919.
15. Leonards JR (1962) Presence of acetylsalicylic in plasma following oral ingestion of aspirin. Proc Soc Exp Biol Med 110:304-308.
16. Lucas D, Berthou F, Dréano Y, Lozach P, Volant A and Ménez JF (1993) Comparison of levels of cytochromes P450, CYP1A2, P450 2E1 and their related monooxygenase activities in human surgical liver samples. Alcohol Clin Exp Res 17:900-905.
17. Lucas D, Ménez C, Girre C, Bodénez P, Hispard E and Ménez JF (1995) Decrease in cytochrome P450 2E1 as assessed by the rate of chlorzoxazone hydroxylation in alcoholics during the withdrawal phase. Alcohol Clin Exp Res 19:362-356.
18. Muntane-Relat J. Ourlin JC, Domergue J and Maurel P (1995) Diffrential effects of cytokines on the inducible expression of CYP1A1, CYP1A2 and P450 3A4 in human heptocytes in primary cultures. Hepatology 22:1143-1153.
19. Newton DJ, Wang RW and Lu AYH (1995) Use of in vitro human metabolism studies in drug development. Drug Metab Dispos 23:154-158.
20. Roberts BJ, Song BJ, Soh Y, Park SS and Shoaf SE (1995) Etnanol induces P450 2E1 by protein stabilization. Role of ubiquitin conjugation in the rapid degradation of P450 2E1. J Biol Chem 270:29632-29635.
21. Rodrigues AD (1994) Use of in vitro human metabolism studies in drug development. Biochem Pharmacol 48:2147-2156.
22. Shimada T, Yamazaki H, Mimura M, Inai Y and Guengerich FP (1994) Interindividual variations in human lever cytochrome P450 enzymes involved in the oxidations of drugs, carcinogens and toxic chemicals. J Pharmacol Exp Ther 270:414-423.
23. Sinclair JF, Jeffery E, Wrighton S, Kostruby V, Szakacs J, Wood S and Sinclair P (1998) Alcohol-mediated increase in acetaminophen heptotoxicity. Role of CYP2E and P450 3A. Biochem Pharmacol 55:1557-1565.
24. Thome J, Zhang J, Davids E, Foley P, Weijers H.G, Wiesbeck GA, Bàning J, Riederer P and Gerlach M (1997) Evidence for increased oxidative stress in alcohol-dependent patients provided by quantification of in vivo salicylate hydroxylation products. Alcohol Clin Exp Res 21:82-85.
25. Zerilli A, Ratanasavanh D, Lucas D, Goasduff T, Dréano Y, Ménard C, Picart D, and Berthou F (1997) Both cytochromes P450 2E1 and 3A isoforms are involved in the O-hydroxylation of p-nitrophenol, a catalytic activity known to be specific of P450 2E1. Chem Res Toxicol 10:1205-1212.